Glucodix ER (Metformin extended release tablet) decreases glucose production in the Liver, decreases absorption of glucose from the intestine and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Its mode of action preserves the beta cells of the pancreas. It causes weight loss.

Glucodix ER has been formulated to gradually release Metformin into the GIT due to the controlled delivery component – Hydroxypropyl Methylcellulose (HPMC)

Gradual release of metaformin
-reduces the GIT disturbance caused by Meormin IR, therefore, promoting adherence. (Poor Adherence is a major obstacle to the benefit of complex drug regimens in the treatment of Type 2 Diabetes).
-Reduces pill burden by supporting one tablet per day administration